[PDF][PDF] BRAF (V600E) mutation and the biology of papillary thyroid cancer
F Frasca, C Nucera, G Pellegriti, P Gangemi… - Endocrine-related …, 2008 - academia.edu
Abstract BRAF (V600E) mutation is the most frequent genetic alteration in papillary thyroid
carcinomas (PTCs) that are 80–90% of all thyroid cancers. We evaluated the relationship …
carcinomas (PTCs) that are 80–90% of all thyroid cancers. We evaluated the relationship …
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma
C Lupi, R Giannini, C Ugolini, A Proietti… - The Journal of …, 2007 - academic.oup.com
Context: Because very few studies have examined the correlation between BRAF mutations
and clinicopathological features of papillary thyroid carcinoma (PTC), we analyzed here a …
and clinicopathological features of papillary thyroid carcinoma (PTC), we analyzed here a …
BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer
Abstract Background The BRAF V600E mutation is the most common genetic alteration
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …
BRAF V600E mutation and Its Association with Clinicopathological Features of Papillary Thyroid Cancer: A Meta-Analysis
C Li, KC Lee, EB Schneider… - The Journal of Clinical …, 2012 - academic.oup.com
Background: There is conflicting literature regarding the association of the BRAF V600E
mutation and aggressive clinicopathological features of papillary thyroid cancer (PTC) …
mutation and aggressive clinicopathological features of papillary thyroid cancer (PTC) …
A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome
A Guerra, L Fugazzola, V Marotta… - The Journal of …, 2012 - academic.oup.com
Context: BRAFV600E is considered a negative prognostic marker in papillary thyroid
carcinoma (PTC), but unexplained conflicting results are present in the literature. In light of …
carcinoma (PTC), but unexplained conflicting results are present in the literature. In light of …
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases
F Basolo, L Torregrossa, R Giannini… - The Journal of …, 2010 - academic.oup.com
Context: Evaluation of the degree of neoplastic infiltration beyond the thyroid capsule
remains a unique parameter that can be evaluated by histopathological examination to label …
remains a unique parameter that can be evaluated by histopathological examination to label …
[HTML][HTML] Relationship between BRAF V600E and clinical features in papillary thyroid carcinoma
C Yan, M Huang, X Li, T Wang… - Endocrine connections, 2019 - ec.bioscientifica.com
Objective To investigate the mutant status of BRAF gene and analyze its relationship to
epidemiological risk factors and clinical outcomes among patients with papillary thyroid …
epidemiological risk factors and clinical outcomes among patients with papillary thyroid …
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness
V Trovisco, P Soares, A Preto, IV de Castro, J Lima… - Virchows Archiv, 2005 - Springer
A high prevalence of the BRAF V600E somatic mutation was recently reported in several
series of papillary thyroid carcinomas (PTC). This mutation appears to be particularly …
series of papillary thyroid carcinomas (PTC). This mutation appears to be particularly …
The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: A meta‐analysis
BACKGROUND: The effects of the BRAFV600E mutation on prognostic factors and poor
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
BRAF V600E Mutation in Papillary Thyroid Carcinoma: Significant Association with Node Metastases and Extra Thyroidal Invasion
A Chakraborty, A Narkar, R Mukhopadhyaya… - Endocrine …, 2012 - Springer
B-Raf (BRAF) is the strongest activator in the downstream of MAP kinase signaling. The
somatic point mutation of BRAF gene (V600E) is the most common and specific event in …
somatic point mutation of BRAF gene (V600E) is the most common and specific event in …
相关搜索
- braf v600e mutation
- clinical features braf v600e
- thyroid cancer meta analysis
- thyroid cancer brafv600e mutation
- thyroid carcinoma node metastases
- thyroid carcinoma significant association
- thyroid cancer prognostic factors
- thyroid carcinoma brafv600e alleles
- thyroid cancer clinicopathological features
- thyroid carcinoma tumour aggressiveness
- thyroid carcinoma poorer outcome
- thyroid carcinoma high percentage
- thyroid carcinoma consecutive cases
- tumor invasiveness thyroid carcinomas
- prevalence of braf mutations
- thyroid carcinoma braf v600e